SCHEMBL14768386

SCHEMBL14768386

NC1(Nc2nccc(-n3ncc4ccccc43)n2)CCCCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 9/20 0.55
MAPK9 P45984 9/20 0.55
MAPK10 P53779 8/20 0.55
CCNT1 O60563 2/20 0.53
CDK1 P06493 2/20 0.53
CCNB1 P14635 2/20 0.53
CDK9 P50750 2/20 0.53
CDK7 P50613 1/20 0.53
CCNH P51946 1/20 0.53
MKNK1 Q9BUB5 3/20 0.52
MKNK2 Q9HBH9 2/20 0.52
CCNE1 P24864 3/20 0.40
CDK2 P24941 3/20 0.40
LRRK2 Q5S007 1/20 0.39
MGAM O43451 1/20 0.34
GAA P10253 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
CYP2C9 P11712 1/20 0.34
CXCR4 P61073 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5094147 0.87 MAPK8 (0.56) MAPK8MAPK9MAPK10CCNT1CDK1
SCHEMBL5096419 0.81 CDK1 (0.51) MAPK8MAPK9MAPK10CCNT1CDK1
SCHEMBL3817313 0.78 MAPK8 (0.47) MAPK8MAPK9MAPK10CCNT1CDK1
SCHEMBL14193418 0.77 MAPK8 (0.79) MAPK8MAPK9MAPK10CCNT1CDK1
SCHEMBL3820942 0.76 CCNT1 (0.44) MAPK8MAPK9MAPK10CCNT1CDK1
SCHEMBL3814433 0.76 MAPK8 (0.50) MAPK8MAPK9MAPK10CCNT1CDK1
SCHEMBL14768385 0.75 MAPK8 (0.62) MAPK8MAPK9MAPK10CCNT1CDK1
SCHEMBL3809069 0.74 MAPK8 (0.41) MAPK8MAPK9MAPK10CCNT1CDK1
SCHEMBL14768384 0.73 MAPK8 (0.79) MAPK8MAPK9MAPK10CCNT1CDK1
SCHEMBL12489602 0.72 CDC7 (0.56) MAPK8MAPK9MAPK10CCNT1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399462-B2 4-[4-(4-benzyloxy-indol-1-yl)-pyrimidin-2-ylamino]-cyclohexanol; autoimmune, inflammatory, metabolic, neurological diseases as well as cancer and pain ROCHE PALO ALTO LLC (US) 2013-03-19 US disclosed